ACIR features Immunetune’s presentation at CIMT Annual Meeting 2022
Accelerating Cancer Immunotherapy Research (ACIR) has featured Immunetune's presentation during the Cancer Immunotherapy (CIMT) Annual Meeting 2022 held May 10-12 in Mainz, Germany. At CIMT, our CSO Jeroen van Bergen presented new preclinical results on our neoantigen...